Fritextsökning
Innehållstyper
-
Cell incubator with built-in microscope
InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.
-
Ansöker om särläkemedelsstatus
Double Bond lämnar ansökan till EMA för Orphan Drug-status för Temodex.
-
Astrapreparat bra vid by-pass
En klinisk studie från Uppsala Clinical Research Centre visar fördelar med Astras preparat jämfört med standardbehandlingen.
-
Köp en begagnad iPhone istället för en ny
Det har under många år varit mycket populärt att äga nya telefoner. Det har blivit väldigt intimt förknippat med status att äga nya saker och telefonen har bliv...
-
Scilifelab startar nytt center
Satsar på enkelcellsbiologi inom plattformen funktionell genomik.
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Brighter förlänger erbjudandet
Ger mer tid till Division By Zeros aktieägare att acceptera bolagets köperbjudande.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Focusing on Medicon Valley
Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies from there will give short presentations to attract partners and investors....
-
Uppsalaföretag beviljas särläkemedelsstatus i USA
Uppsalaföretaget Beactica Therapeutics har nu beviljats särläkemedelsstatus i USA för sitt läkemedel BEA-17 för behandling av glioblastom.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Köper virtual reality-teknik
Brighter köper e-hälsoföretaget Division By Zero.
-
Anna Törner: ”Mitt kvantifierade liv”
”Uttrycket om att man inte ser skogen för alla träd känns nyaktuellt i kontexten wearbales. Det är lätt att fångas av tanken att ju mer vi mäter, desto mer vet ...
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
New CEO to Swedish Tillotts Pharma
The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.
-
Control of blood vessels can treat obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
Utbyte av viktig patientinformation ska underlättas
Sveriges första nationella gemensamma e-hälsospecifikation, NGS, har nu sett dagens ljus, meddelar E-hälsomyndigheten.
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
BREAKING